Eris Lifesciences Ltd posts consolidated PAT of Rs. 120.30 crores in Q2FY23

Eris Lifesciences Limited has reported Consolidated financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 465.684 crores during the period ended September 30, 2022 as compared to Rs. 401.321 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 120.304 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 94.577 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 8.84 for the period ended September 30, 2022 as compared to Rs. 6.95 for the period ended June 30, 2022.

Financials	Q2 FY2023	Q1 FY2023	% Change
Total Income	₹ 465.684 crs	₹401.321 crs	16.04%
Net Profit	₹120.304 crs	₹94.577 crs	27.20%
EPS	₹8.84	₹6.95	27.19%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 465.684 crores during the period ended September 30, 2022 as compared to Rs.366.657 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.120.304 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.118.393 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.8.84 for the period ended September 30, 2022 as compared to Rs.8.71 for the period ended September 30, 2021.

Financials	Q2 FY2023	Q2 FY2022	% Change
Total Income	₹ 465.684 crs	₹366.657 crs	27.01%
Net Profit	₹120.304 crs	₹118.393 crs	1.61%
EPS	₹8.84	₹8.71	1.49%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.867.005 crores during the 6 Months period ended September 30, 2022 as compared to Rs.721.792 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.214.881 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.225.052 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.15.79 for the 6 Months period ended September 30, 2022 as compared to Rs.16.56 for the 6 Months period ended September 30, 2021.

Financials	Half Year Ended FY2023	Half Year Ended FY2022	% Change
Total Income	₹867.005 crs	₹721.792 crs	20.12%
Net Profit	₹214.881 crs	₹225.052 crs	-4.52%
EPS	₹15.79	₹16.56	-4.65%

Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 707.65 as compared to the previous close of Rs. 729.05. The total number of shares traded during the day was 5060 in over 992 trades.

The stock hit an intraday high of Rs. 742.70 and intraday low of 701.70. The net turnover during the day was Rs. 3642228.00.

Source : Equity Bulls

Keywords

ErisLifesciences Q2FY23 H1FY23 ResultUpdate